Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon

Joseph Fokam, Romina Salpini, Maria Mercedes Santoro, Valeria Cento, Carlo Federico Perno, Vittorio Colizzi, Peter Martins Ndumbe, Charles Fokunang Ntungen, Suzie Moyo Ndiang Tetang, Aubin Joseph Nanfack, Désiré Augustin Takou Komego, Giulia Cappelli

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance. With the goal of attaining 100% pediatric ART coverage in Cameroon, strategies to limit the spread of HIV resistance among children are very important. Methods: From June 2009 through February 2011, 92 HIV-1-infected children (41 ART-naive, 51 failing first-line ART) living in Yaoundé, Cameroon, were enrolled; HIV-1 Prot-RT genotypic resistance testing (GRT) was performed using an inhouse assay. Among 40 children failing first-line ART, treatment response was evaluated at weeks 24 and 48 after treatment was changed, based on GRT results. Results: The mean age was 72 months both for children who were drug-naive and those failing ART (range: 3-144 and 12-144, respectively), with a mean viremia of 5.59 log and 4.71 log RNA copies/mL, a median CD4 of 17% (588 cells/μL) and 23% (719 cells/μL), respectively. Median time-to-treatment failure was 610 days. A prevalence of 4.9% and 90% drug resistance was observed, respectively, among children who were drug-naive and those failing first-line ART, with circulating recombinant form CRF02-AG as the most prevalent clade (58.6% and 62%, respectively). After a change to GRT-based treatment, more than 90% of children had viremia

Original languageEnglish
Pages (from-to)1062-1068
Number of pages7
JournalPediatric Infectious Disease Journal
Volume30
Issue number12
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Cameroon
Drug Resistance
Pharmaceutical Preparations
Therapeutics
Viremia
HIV-1
HIV
Treatment Failure
RNA
Pediatrics

Keywords

  • antiretroviral drug resistance
  • Cameroon
  • children
  • human immunodeficiency virus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon. / Fokam, Joseph; Salpini, Romina; Santoro, Maria Mercedes; Cento, Valeria; Perno, Carlo Federico; Colizzi, Vittorio; Ndumbe, Peter Martins; Fokunang Ntungen, Charles; Ndiang Tetang, Suzie Moyo; Nanfack, Aubin Joseph; Takou Komego, Désiré Augustin; Cappelli, Giulia.

In: Pediatric Infectious Disease Journal, Vol. 30, No. 12, 12.2011, p. 1062-1068.

Research output: Contribution to journalArticle

Fokam, J, Salpini, R, Santoro, MM, Cento, V, Perno, CF, Colizzi, V, Ndumbe, PM, Fokunang Ntungen, C, Ndiang Tetang, SM, Nanfack, AJ, Takou Komego, DA & Cappelli, G 2011, 'Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon', Pediatric Infectious Disease Journal, vol. 30, no. 12, pp. 1062-1068. https://doi.org/10.1097/INF.0b013e31822db54c
Fokam, Joseph ; Salpini, Romina ; Santoro, Maria Mercedes ; Cento, Valeria ; Perno, Carlo Federico ; Colizzi, Vittorio ; Ndumbe, Peter Martins ; Fokunang Ntungen, Charles ; Ndiang Tetang, Suzie Moyo ; Nanfack, Aubin Joseph ; Takou Komego, Désiré Augustin ; Cappelli, Giulia. / Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon. In: Pediatric Infectious Disease Journal. 2011 ; Vol. 30, No. 12. pp. 1062-1068.
@article{189e63a304cb4f099f4fee5af3a79736,
title = "Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon",
abstract = "Background: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance. With the goal of attaining 100{\%} pediatric ART coverage in Cameroon, strategies to limit the spread of HIV resistance among children are very important. Methods: From June 2009 through February 2011, 92 HIV-1-infected children (41 ART-naive, 51 failing first-line ART) living in Yaound{\'e}, Cameroon, were enrolled; HIV-1 Prot-RT genotypic resistance testing (GRT) was performed using an inhouse assay. Among 40 children failing first-line ART, treatment response was evaluated at weeks 24 and 48 after treatment was changed, based on GRT results. Results: The mean age was 72 months both for children who were drug-naive and those failing ART (range: 3-144 and 12-144, respectively), with a mean viremia of 5.59 log and 4.71 log RNA copies/mL, a median CD4 of 17{\%} (588 cells/μL) and 23{\%} (719 cells/μL), respectively. Median time-to-treatment failure was 610 days. A prevalence of 4.9{\%} and 90{\%} drug resistance was observed, respectively, among children who were drug-naive and those failing first-line ART, with circulating recombinant form CRF02-AG as the most prevalent clade (58.6{\%} and 62{\%}, respectively). After a change to GRT-based treatment, more than 90{\%} of children had viremia",
keywords = "antiretroviral drug resistance, Cameroon, children, human immunodeficiency virus",
author = "Joseph Fokam and Romina Salpini and Santoro, {Maria Mercedes} and Valeria Cento and Perno, {Carlo Federico} and Vittorio Colizzi and Ndumbe, {Peter Martins} and {Fokunang Ntungen}, Charles and {Ndiang Tetang}, {Suzie Moyo} and Nanfack, {Aubin Joseph} and {Takou Komego}, {D{\'e}sir{\'e} Augustin} and Giulia Cappelli",
year = "2011",
month = "12",
doi = "10.1097/INF.0b013e31822db54c",
language = "English",
volume = "30",
pages = "1062--1068",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon

AU - Fokam, Joseph

AU - Salpini, Romina

AU - Santoro, Maria Mercedes

AU - Cento, Valeria

AU - Perno, Carlo Federico

AU - Colizzi, Vittorio

AU - Ndumbe, Peter Martins

AU - Fokunang Ntungen, Charles

AU - Ndiang Tetang, Suzie Moyo

AU - Nanfack, Aubin Joseph

AU - Takou Komego, Désiré Augustin

AU - Cappelli, Giulia

PY - 2011/12

Y1 - 2011/12

N2 - Background: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance. With the goal of attaining 100% pediatric ART coverage in Cameroon, strategies to limit the spread of HIV resistance among children are very important. Methods: From June 2009 through February 2011, 92 HIV-1-infected children (41 ART-naive, 51 failing first-line ART) living in Yaoundé, Cameroon, were enrolled; HIV-1 Prot-RT genotypic resistance testing (GRT) was performed using an inhouse assay. Among 40 children failing first-line ART, treatment response was evaluated at weeks 24 and 48 after treatment was changed, based on GRT results. Results: The mean age was 72 months both for children who were drug-naive and those failing ART (range: 3-144 and 12-144, respectively), with a mean viremia of 5.59 log and 4.71 log RNA copies/mL, a median CD4 of 17% (588 cells/μL) and 23% (719 cells/μL), respectively. Median time-to-treatment failure was 610 days. A prevalence of 4.9% and 90% drug resistance was observed, respectively, among children who were drug-naive and those failing first-line ART, with circulating recombinant form CRF02-AG as the most prevalent clade (58.6% and 62%, respectively). After a change to GRT-based treatment, more than 90% of children had viremia

AB - Background: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance. With the goal of attaining 100% pediatric ART coverage in Cameroon, strategies to limit the spread of HIV resistance among children are very important. Methods: From June 2009 through February 2011, 92 HIV-1-infected children (41 ART-naive, 51 failing first-line ART) living in Yaoundé, Cameroon, were enrolled; HIV-1 Prot-RT genotypic resistance testing (GRT) was performed using an inhouse assay. Among 40 children failing first-line ART, treatment response was evaluated at weeks 24 and 48 after treatment was changed, based on GRT results. Results: The mean age was 72 months both for children who were drug-naive and those failing ART (range: 3-144 and 12-144, respectively), with a mean viremia of 5.59 log and 4.71 log RNA copies/mL, a median CD4 of 17% (588 cells/μL) and 23% (719 cells/μL), respectively. Median time-to-treatment failure was 610 days. A prevalence of 4.9% and 90% drug resistance was observed, respectively, among children who were drug-naive and those failing first-line ART, with circulating recombinant form CRF02-AG as the most prevalent clade (58.6% and 62%, respectively). After a change to GRT-based treatment, more than 90% of children had viremia

KW - antiretroviral drug resistance

KW - Cameroon

KW - children

KW - human immunodeficiency virus

UR - http://www.scopus.com/inward/record.url?scp=81855221740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855221740&partnerID=8YFLogxK

U2 - 10.1097/INF.0b013e31822db54c

DO - 10.1097/INF.0b013e31822db54c

M3 - Article

C2 - 21817951

AN - SCOPUS:81855221740

VL - 30

SP - 1062

EP - 1068

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 12

ER -